Is AMC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Box-Office Recovery and Film Slate, with revenue (ttm) at ~$5.23 billion; Q2 2026 ~$1.6 billion (up ~14% YoY). The bear case rests on the dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. Analysts covering it are spread from $2.20 to $5.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $2.20, -24.4% from the $2.91 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Box-Office Recovery and Film Slate. AMC's core thesis is a continued rebound in theatrical attendance. The most optimistic analyst target on AMC is $5.00, +71.8% from the $2.91 price. That figure is only reachable if this thesis works close to its best case.

The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. Dilution is a second, recurring risk; the share count has grown by hundreds of millions over the past few years through repeated equity sales, including offerings in 2026, which mechanically reduces value per share even when the business improves. The company still lost about $554 million over the last twelve months on a GAAP basis. The secular shift toward streaming and shortened theatrical windows pressures long-run theater demand, and attendance is volatile and dependent on a film slate AMC does not control, so a weak release year can quickly reverse the recovery. After an 85% rise in 2026 the stock trades just below the roughly $3.20 average analyst target, and the meme-stock legacy means the share price can move on retail sentiment and short interest rather than fundamentals. The most pessimistic published target is $2.20, -24.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

AMC Entertainment Holdings, Inc. engages in the theatrical exhibition business in the United States and internationally. It owns, operates, or has interests in theatres.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Box-Office Recovery and Film Slate) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

AMC Entertainment is the largest movie-theater chain in the United States and the world, operating theatres in the U.S. and Europe under brands including AMC and Odeon. It earns revenue primarily from box-office ticket sales and from high-margin food and beverage concessions, with additional income from on-screen advertising and premium large-format screens. Its results depend heavily on the strength of the studio film slate each year.

It depends entirely on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is a continuing box-office recovery, a strong Q2 2026 (revenue up 14%, adjusted EBITDA up 70%, positive free cash flow), and a refinancing that pushed almost all maturities into the next decade. The bear case is roughly $3.85 billion in corporate debt, repeated share dilution that has multiplied the share count, ongoing GAAP losses, the secular pressure of streaming, and a stock that already rose about 85% in 2026. Both can be true at once.

As of the end of Q2 2026 (June 30), AMC reported approximately $3.85 billion in corporate borrowings against roughly $778 million of cash and a stockholders' deficit of about $1.45 billion; total debt including lease obligations is about $7.7 billion. In early October 2026 it closed a roughly $3.97 billion refinancing that moved almost all remaining due dates into the next decade, which reduces near-term refinancing risk but does not shrink the overall debt load.